Allen Clarkson resumes & CV records
Resumes
Director
Location:
New York, NY
Industry:
Apparel & Fashion
Work:
Croker Interprises
Director
Director
Allen B Clarkson, Age 8142 Kays Way, Warwick, NY 10990
Allen Clarkson Phones & Addresses
42 Fox Hill Rd, Warwick, NY 10990 (845) 544-1479
4 Washington Square Vlg, New York, NY 10012 (212) 777-6619
42 Kays Way, Warwick, NY 10990 (212) 777-6619
Social networks
Allen B Clarkson
Linkedin
Work
Company:
Croker interprises
Position:
Director
Education
Degree:
Associate degree or higher
Industries
Apparel & Fashion
Mentions for Allen B Clarkson
Publications & IP owners
Us Patents
Method And Compositions For Treatment Or Prevention Of Pneumocystic Carinii Infections
US Patent:
5462969, Oct 31, 1995
Filed:
Feb 4, 1994
Appl. No.:
8/192404
Inventors:
Allen B. Clarkson - New York NY
Robert W. Grady - Kinnelon NJ
Robert W. Grady - Kinnelon NJ
Assignee:
New York University - New York NY
International Classification:
A61K 3119
A61K 31155
A61K 31155
US Classification:
514575
Abstract:
The present invention provides methods for treating and preventing the onset of Pneumocytis carinii pneumonia (PCP) comprising administering to a mammal in need of such treatment or prevention an effective amount of a pharmaceutically acceptable iron chelator. This invention also provides a method for treating or preventing the onset of PCP comprising administering to a mammal in need of such treatment or prevention a composition comprising the following components: (a) a pharmaceutically acceptable iron chelator; (b) a compound selected from trimethoprim/sulfamethoxazole and pentamidine; and (c) a pharmaceutically compatible carrier or diluent, wherein the amounts of said component (a) and said component (b) in combination are effective in treating said pneumonia. Also provided is a composition for the treatment or prevention of PCP.
Method For The Control Of Trypanosomiasis
US Patent:
4136198, Jan 23, 1979
Filed:
Aug 13, 1976
Appl. No.:
5/714156
Inventors:
Allen B. Clarkson - New York NY
Fredrick H. Brohn - New York NY
Fredrick H. Brohn - New York NY
Assignee:
The Rockefeller University - New York NY
International Classification:
A61K 3116
US Classification:
424320
Abstract:
A composition comprising from 0. 02 to 17 parts by weight of glycerol per part by weight of an iron chelating agent selected from the group consisting of salicyl hydroxyamic acid; 2,3- and 3,4-dihydroxy benzoic acid; and halobenzohydroxamic; e. g. , m-iodobenzohydroxamic acid and m-chlorobenzohydroxamic acid; as well as their C. sub. 1 to C. sub. 4 alkyl esters. When this composition is administered parenterally, it is found to block aerobic and anaerobic glucose catabolism and thereby accomplish control of several trypanosomes, including Trypanosoma brucei, T. gambiensi, T. rhodesiensi, T. equiperdum, T. evansi, T. congolense and T. vivax. In mammals, the therapeutic dosage is calculated to provide at least 138 mg/kg of body weight of glycerol and at least 96 mg/kg of body weight of the iron chelating agent.
Method And Compositions For Treating Pneumocystic Carini Infections
US Patent:
5158979, Oct 27, 1992
Filed:
Apr 19, 1989
Appl. No.:
7/340344
Inventors:
Allen B. Clarkson - New York NY
Robert W. Grady - Kinnelon NJ
Robert W. Grady - Kinnelon NJ
Assignee:
New York University - New York NY
International Classification:
A61K 3119
US Classification:
514575
Abstract:
The present invention provides methods for treating and preventing the onset of Pneumocystis carinii pneumonia (PCP) comprising administering to a mammal in need to such treatment or prevention an effective amount of a pharmaceutically acceptable iron chelator. This invention also provides a method for treating or preventing the onset of PCP comprising administering to a mammal in need of such treatment or prevention a composition comprising the following components: (a) a pharmaceutically acceptable iron chelator; (b) a compound selected from trimethoprim/sulfamethoxazole and pentamidine; and (c) a pharmaceutically compatible carrier or diluent, wherein the amounts of said component (a) and said component (b) in combination are effective in treating said pneumonia. Also provided is a composition for the treatment or prevention of PCP.
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.